2011;6(3):e17971 [9] Jiang X, Tian Q, Wang Y, Zhou XW, Xie JZ, Wang JZ, Zhu LQ.Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C
This triple mechanism distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 agonist)
The structural modification of this peptide includes an arginine substitution at position 3 and an extended amino acid sequence, which influences receptor binding affinity and reduces susceptibility to proteolytic enzymes in controlled experimental conditions
STEP-1 lasted 68 weeks, SURMOUNT-1 lasted 72 weeks, and TRIUMPH-4 lasted 68 weeks, but the latter was conducted on a specific population (obesity with knee osteoarthritis)
According to Mounjaros data, individuals with elevated BMI and without severe metabolic complications could reap the greatest benefits